Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNIC.L Regulatory News (CNIC)

  • There is currently no data for CNIC

Share Buyback Programme

30 Dec 2022 07:00

RNS Number : 2607L
CentralNic Group PLC
30 December 2022
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

30 December 2022

 

CENTRALNIC GROUP PLC

("CentralNic" or "the Company" or "the Group")

 

Share Buyback Programme

CentralNic Group Plc (AIM: CNIC), the global internet software company that derives recurring revenue from marketplaces for Online Presence and Online Marketing services, further to its announcement on 12 December 2022, is pleased to inform that its maiden share buyback programme of ordinary shares of £0.001 each ("Ordinary Shares") up to a maximum aggregate consideration of £4 million (the "Buyback Programme") launches effective today.

The Board considers the Buyback Programme to be in the best interests of all shareholders, given the cash generative nature of the business and the strong performance compared to expectations. It reflects the Group's more balanced future approach to capital allocation.

The Company has appointed its broker, Zeus Capital Limited ("Zeus"), to manage the Buyback Programme to repurchase Ordinary Shares on its behalf and entered into an irrevocable and non-discretionary arrangement on 29 December 2022 with Zeus and Arden Partners PLC to enable Zeus to conduct the Buyback Programme on a broker-managed basis. Zeus will make trading decisions in relation to the Buyback Programme independently of the Company, within certain defined parameters.

The Buyback Programme commences today and will end no later than the date upon which the aggregate consideration paid for Ordinary Shares reaches £4 million, or by the time of the Company's 2023 Annual General Meeting which is to be held no later than 30 June 2023 (the "Buyback Period"). During the Buyback Period the Company has no power to invoke any changes to the authority and any purchases will be undertaken by Zeus, acting independently of, and uninfluenced by the Company.

 

Ordinary Share repurchases will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volume. The Buyback Programme is in accordance with the Company's general authority to purchase a maximum of 28,866,000 Ordinary Shares, granted by its shareholders at the Annual General Meeting held on 4 May 2022, including that the maximum price paid per Ordinary Share will be no more than: a) 105 per cent. of the average trading price of the Ordinary Shares as derived from the middle market quotations for an Ordinary Share on the London Stock Exchange Daily Official List for the five trading days immediately preceding the date on which an Ordinary Share is contracted to be purchased; and b) the higher of the price of the last independent trade and the highest current independent purchase bid for Ordinary Shares on the trading venue where the purchase is carried out.

 

Under the Buyback Programme, the repurchased shares will either be cancelled or held in treasury at the Company's discretion for later reissue or cancellation. Shares held in treasury are not entitled to dividends and have no voting rights at the Company's general meetings.

 

The Buyback Programme will be conducted within the parameters of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation 2016/1052/EU (each as in force in the UK from time to time, including where relevant pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2019.

 

The Company will make further announcements in due course following any share purchases conducted through the Buyback Programme.

 

The Company confirms that it currently has no unpublished price sensitive information.

 

For further information:

 

CentralNic Group Plc

 

Michael Riedl, Chief Executive Officer

+44 (0) 203 388 0600

 

Don Baladasan, Group Managing Director

 

 

 

 

Zeus (NOMAD and Broker)

 

Nick Cowles / Jamie Peel / James Edis (Investment Banking)

+44 (0) 161 831 1512

Dominic King (Corporate Broking) 

+44 (0) 203 829 5000

 

 

Berenberg (Joint Broker)

Mark Whitmore / Richard Andrews / Alix Mecklenburg-Solodkoff

 

SEC Newgate (for Media)

+44 (0) 20 3207 7800

 

Bob Huxford / Harry Handyside

 

+44 (0) 203 757 6880

centralnic@secnewgate.co.uk

 

 

 

The person responsible for arranging for the release of this announcement on behalf of CentralNic is Michael Riedl, CEO

 

About CentralNic Group Plc

CentralNic (AIM: CNIC) is a London-based AIM-listed company which drives the growth of the global digital economy by developing and managing online marketplaces allowing businesses globally to buy subscriptions to domain names for websites and email, monetise their websites, and acquire customers online. Its core growth strategy is identifying and acquiring cash-generative businesses in its industry with annuity revenue streams and exposure to growth markets and migrating them onto the CentralNic software and operating platforms. For more information please visit: www.centralnicgroup.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFEWEEUEESEIE
Date   Source Headline
15th Dec 202211:23 amRNSDirectors' Dealings
12th Dec 20227:00 amRNSLEADERSHIP CHANGE, UPDATE, SHARE BUYBACK INTENTION
30th Nov 20229:58 amRNSDirectors’ Dealings
28th Nov 20227:00 amRNSHolding(s) in Company
28th Nov 20227:00 amRNSDirectors’ Dealings
22nd Nov 20227:00 amRNSNINE MONTHS ENDED 30 SEP 2022 FINANCIAL RESULTS
9th Nov 20227:00 amRNSNotice of Results
31st Oct 202211:00 amRNSSuccessful Completion of Refinancing
26th Oct 20227:00 amRNSAcquisition Announcement
24th Oct 20221:32 pmRNSDirectors' Dealings
17th Oct 20227:00 amRNSQ3 Traing Upate, Refinancing Notice of Results
17th Oct 20227:00 amRNSQ3 Trading Update, Refinancing & Notice of Results
12th Oct 20221:59 pmRNSDirectors’ Dealings
12th Oct 202210:36 amRNSHolding(s) in Company - Replacement
11th Oct 20224:01 pmRNSHolding(s) in Company
11th Oct 20223:59 pmRNSHolding(s) in Company
7th Oct 20227:00 amRNSDirectors' Dealings
5th Oct 20227:00 amRNSDirectors’ Dealings
29th Sep 20227:00 amRNSDirectors’ Dealings
26th Sep 20227:00 amRNSDirectors' Dealings
14th Sep 20227:01 amRNSBoard Changes
14th Sep 20227:00 amRNSAcquisition Announcement
6th Sep 20225:38 pmRNSDirectors' Dealings
30th Aug 20227:00 amRNSSIX MONTHS ENDED 30 JUNE 2022 FINANCIAL RESULTS
29th Jul 20225:07 pmRNSDirectors' Dealings
25th Jul 20227:00 amRNSExercise of Options
18th Jul 20227:02 amRNSKeyDrive SA Final Add. Consideration Determined
18th Jul 20227:01 amRNSDirectors' Dealings
18th Jul 20227:00 amRNSH1 2022 Trading Update and Notice of Results
23rd May 20227:00 amRNSTHREE MONTHS ENDED 31 MARCH 2022 FINANCIAL RESULTS
4th May 20225:00 pmRNSResult of AGM
25th Apr 20227:00 amRNSQ1 2022 Update, Outlook & Notice of Results
7th Apr 20227:00 amRNSDirector Dealing
4th Apr 20223:49 pmRNSAnnual Report 2021 and Notice of Q1 Update and AGM
29th Mar 202212:22 pmRNSHolding(s) in Company
18th Mar 20221:20 pmRNSResult of Open Offer And Notice of Results
8th Mar 20225:14 pmRNSHolding(s) in Company
8th Mar 20221:52 pmRNSHolding(s) in Company
8th Mar 20227:00 amRNSAcquisition of VGL completed and FT1000 inclusion
7th Mar 20227:00 amRNSShare Awards and Exercise of Options
2nd Mar 20223:58 pmRNSDirectors' Dealings
2nd Mar 20223:54 pmRNSHolding(s) in Company
2nd Mar 202211:13 amRNSHolding(s) in Company
28th Feb 202210:07 amRNSResult of Placing and Launch of Open Offer
28th Feb 20227:01 amRNSProposed Acquisition, Placing and Open Offer
28th Feb 20227:00 amRNSUnaudited Preliminary Results Full Year 2021
14th Feb 20227:00 amRNSTrading Update, Acquisitions, Presentations
3rd Feb 20227:00 amRNSInvestor Presentation
17th Jan 20227:00 amRNSTrading Update and Notice of Results
6th Dec 20217:00 amRNSAcquisition Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.